Latest Articles

Publication Date
All News Scientific
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - The AI Journal

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen The AI Journal

Published: Oct. 18, 2025, 10:28 a.m.
Read Full Article
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - Business Wire

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen Business Wire

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer - geneonline.com

Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer geneonline.com

Published: Oct. 14, 2025, 6:39 p.m.
Read Full Article
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - Bioengineer.org

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival Bioengineer.org

Published: Oct. 14, 2025, 5:14 p.m.
Read Full Article
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - BIOENGINEER.ORG

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival BIOENGINEER.ORG

Published: Oct. 14, 2025, 5:14 p.m.
Read Full Article
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - bioengineer.org

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival bioengineer.org

Published: Oct. 14, 2025, 5:14 p.m.
Read Full Article
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org

Published: Oct. 14, 2025, 4:49 p.m.
Read Full Article
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG

Published: Oct. 14, 2025, 4:49 p.m.
Read Full Article
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer - CancerNetwork

Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer CancerNetwork

Published: Oct. 13, 2025, 10:05 p.m.
Read Full Article
Researchers awarded $11.2M grant to close endometrial cancer survival gap - UNC Gillings School of Global Public Health

Researchers awarded $11.2M grant to close endometrial cancer survival gap UNC Gillings School of Global Public Health

Published: Oct. 9, 2025, 4:10 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!